Tirzepatide may be recommended for patients who want the potentially greater weight loss shown in clinical trials, or for patients who haven't responded adequately to semaglutide
So lets hear what she had to say
Research from Levity, a digital health platform providing behavioral support and emotional tracking tools for people using GLP-1 medications, now shows that nearly one in three GLP-1 users admit to skipping or delaying a dose to avoid the logistics or embarrassment of traveling with injectables like Ozempic, Wegovy, or Mounjaro
Some individuals may regain weight after discontinuing semaglutide, particularly if they revert to prior eating or exercise habits
Your prescription can be send to your pharmacy to be filled, or your service will ship your medication directly to your door
Issues such as small sample sizes, lack of control groups, and short follow-up periods further weaken the validity of these studies